site stats

Hangzhou innogate pharma

WebPharmaceutical Companies Hangzhou Innogate Pharma Sorry, we didn't find any related vantage articles. Please visit the vantage homepage for our latest articles or search our … WebSep 7, 2024 · College of Material, Chemistry and Chemical Engineering, Hangzhou Normal University Hangzhou Zhejiang 311121 PR China. ORCIDs linked to this article. Ye Y, 0000-0001-5279-8104, Shanghai University; Li S, 0000-0003-1480-9292, Hangzhou Normal University; Ye XY, 0000-0003-3739-0930, Hangzhou Innogate Pharma Co. Ltd. …

SHANGHAI BLUERAY BIOPHARMA CO LTD innovation strategy

WebFeb 15, 2024 · Hangzhou Innogate Pharma Co. Ltd. has identified kinesin-like protein KIF18A inhibitors reported to be useful for the treatment of cancer and viral infections. All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. WebPOLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR - HANGZHOU INNOGATE PHARMA CO., LTD. Title: POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR … liesbeth raepsaet https://boudrotrodgers.com

Hangzhou Pharma & Chem Co., Ltd. - Active pharmaceutical …

Web4 d Drug Discovery , Hangzhou Innogate Pharma Co., Ltd , Hangzhou , Zhejiang Province , China. PMID: 30621465 DOI: 10.1080/13543776.2024.1567713 Abstract Introduction: … WebPOLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR - HANGZHOU INNOGATE PHARMA CO., LTD. Title: POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR Document Type and Number: United States Patent Application 20240095043 Kind Code: A1 Abstract: The present invention provides a class of compounds containing tricyclic … WebOct 12, 2024 · R 1 is aryl, heteroaryl or 6-membered monocyclic heterocyclyl (including saturated and unsaturated); aryl, heteroaryl or monocyclic heterocyclyl herein may be optionally and independently substituted by 1-3 substituents each independently selected from the group consisting of: halogen, C 1-4 alkyl, C 1-4 halogenated alkyl, C 2-4 … mcmellon bros. incorporated

BRIEF-CSPC Pharmaceutical Group Unit Entered Agreement With …

Category:Binding Database

Tags:Hangzhou innogate pharma

Hangzhou innogate pharma

Affinity Data by USPatent=US10358451

WebInnogate Pharma Co., Ltd. May 2024 - Present4 years 11 months Hangzhou, Zhejiang, China Chief Scientific Officer Global Health Drug Discovery Institute Sep 2024 - May … WebOther pharma companies with tricyclic IDO1 inhibitors in their pipeline at present are Hangzhou Innogate Pharma Co., Ltd. [88], Shanghai De Novo Pharmatech Co., Ltd. …

Hangzhou innogate pharma

Did you know?

WebHangzhou Innogate Pharma Company, Ltd. Locations. Hangzhou Innogate Pharma Company, Ltd. Locations. Go back to Hangzhou Innogate Pharma Company, Ltd. 's … WebHangzhou Innogate Pharma Co., Ltd. US Patent: Assay Description In vitro TDO enzymatic activity was determined in a mixture of 50 mM potassium phosphate buffer, pH 6.5; 200 nM human TDO enzyme, 300 μM L-Trypt... US Patent US10358451 (2024) BindingDB Entry DOI: 10.7270/Q26112P0: More data for this Ligand-Target Pair: …

WebIt filed its patents most often in China, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are HANGZHOU INNOGATE PHARMA CO LTD, MNEMOSYNE PHARMACEUTICALS INC and DAJITI FARMAS JUTIKAL KO LTD. Map … WebOther pharma companies with tricyclic IDO1 inhibitors in their pipeline at present are Hangzhou Innogate Pharma Co., Ltd. [88], Shanghai De Novo Pharmatech Co., Ltd. [89,90] and Redx Pharma plc [91,92]. In summary, the modification mainly focus on the replacements of the benzene motif by 5- or 6- membered heteroaryl groups to fill pocket …

WebReference： [1]Current Patent Assignee: HANGZHOU INNOGATE PHARMA CO LTD - CN113583026, 2024, A Location in patent: Paragraph 0247-0248; 0252 9 [ 2737327-57-8 ] WebDec 12, 2024 · A class of compounds containing a tricyclic heteroaryl group is provided. Specifically, a compound of the structure represented by the following formula (I) (each group is as defined in the specification), a pharmaceutical composition containing the compound of the formula (I), and their isotope derivatives, chiral isomers, allosterics ...

WebJan 31, 2024 · Hangzhou Innogate Pharma synthesizes new KAT6A inhibitors Jan. 31, 2024 Hangzhou Innogate Pharma Co. Ltd. has discovered histone acetyltransferase KAT6A inhibitors reported to be useful for the treatment …

Web专利顾如平台提供关于 protein kinase inhibitors 的专利信息查询，本次查询共找到了37545条关于 protein kinase inhibitors 的专利信息，专利顾如是创新者都在用的专利研发平台,专利检索,专利深度分析跟踪平台 mcm elegante hotel and suites lubbockWebHANGZHOU INNOGATE PHARMA CO LTD has a total of 39 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2016. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and … liesbeth reynaertWebHangzhou Innogate Pharma Co., Ltd. US Patent. Ligand BDBM408633 (US10358451, Compound 18k-2) Show SMILES. Show InChI. Affinity Data IC50: 100nM Assay … liesbeth reyndersWebJun 7, 2024 · Assigned to Hangzhou Innogate Pharma Co., Ltd., Zhejiang (CN) Filed by Hangzhou Innogate Pharma Co., Ltd., Zhejiang (CN) PCT Filed May 27, 2024, PCT … liesbeth rasker podcastliesbeth reiscenter herenthoutWebHangzhou Innogate Pharma Co., Ltd. US Patent. Ligand BDBM408630 (4-(2-(6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-h...) Show SMILES. Show InChI. Affinity Data IC50: 100nM Assay Description: In vitro IDO1 enzymatic activity was determined in a mixture of 50 mM MES buffer at pH 6.5; 200 nM human IDO enzyme, 150 μM L ... liesbeth renneWeb2 articles for Hangzhou Innogate Pharma Co., Ltd. The following articles (labelled with PubMed ID or TBD) are for your review; PMID Article Title Published Deposition; … mc melody lamborghini